Janet Andersen

6.8k total citations · 2 hit papers
72 papers, 4.4k citations indexed

About

Janet Andersen is a scholar working on Epidemiology, Hematology and Infectious Diseases. According to data from OpenAlex, Janet Andersen has authored 72 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 18 papers in Hematology and 14 papers in Infectious Diseases. Recurrent topics in Janet Andersen's work include Acute Myeloid Leukemia Research (11 papers), Chronic Lymphocytic Leukemia Research (9 papers) and HIV/AIDS Research and Interventions (8 papers). Janet Andersen is often cited by papers focused on Acute Myeloid Leukemia Research (11 papers), Chronic Lymphocytic Leukemia Research (9 papers) and HIV/AIDS Research and Interventions (8 papers). Janet Andersen collaborates with scholars based in United States, South Africa and Ireland. Janet Andersen's co-authors include Lauren Komarow, Andrew Zolopa, William G. Powderly, Tun Liu, Marion G. Peters, Kenneth E. Sherman, Evelyn Hogg, Ian Sanne, Raymond T. Chung and Margaret James Koziel and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Janet Andersen

72 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Peginterferon Alfa-2a plus Ribavirin versus Interferon Alfa-2a plus Ribavirin for Chronic Hepatitis C in HIV-Coinfected Persons

2004 674 citations Janet Andersen, Kenneth E. Sherman et al. New England Journal of Medicine profile →
Expression of Apoptosis-Regulating Proteins in Chronic Lymphocytic Leukemia: Correlations With In Vitro and In Vivo Chemoresponses

1998 534 citations Janet Andersen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Janet Andersen United States	33	1.6k	1.1k	929	808	725	72	4.4k
Michael C. Sneller United States	41	836 0.5×	736 0.7×	964 1.0×	196 0.2×	723 1.0×	105	6.1k
Giovanni Barillari Italy	35	1.2k 0.7×	756 0.7×	1.5k 1.6×	396 0.5×	2.0k 2.8×	141	6.0k
María Rios United States	38	844 0.5×	1.1k 1.1×	301 0.3×	562 0.7×	672 0.9×	212	5.3k
Julie M. Cherrington United States	52	1.8k 1.1×	1.2k 1.2×	3.7k 4.0×	610 0.8×	2.3k 3.1×	88	8.9k
Rosemary Rochford United States	41	2.0k 1.2×	882 0.8×	695 0.7×	691 0.9×	2.3k 3.1×	141	5.9k
Hernán Valdez United States	43	1.4k 0.9×	1.7k 1.7×	341 0.4×	381 0.5×	671 0.9×	154	7.1k
Erhard Seifried Germany	46	1.5k 0.9×	860 0.8×	1.4k 1.5×	730 0.9×	1.6k 2.2×	298	7.7k
E. Graham Davies United Kingdom	29	1.6k 1.0×	656 0.6×	1.0k 1.1×	236 0.3×	821 1.1×	71	4.4k
Jeffrey Laurence United States	40	935 0.6×	2.4k 2.3×	678 0.7×	137 0.2×	617 0.9×	130	5.4k
Georg Heß Germany	39	1.4k 0.9×	268 0.3×	1.1k 1.2×	1.2k 1.5×	2.2k 3.1×	192	6.6k

Countries citing papers authored by Janet Andersen

Since Specialization

Citations

This map shows the geographic impact of Janet Andersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janet Andersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janet Andersen more than expected).

Fields of papers citing papers by Janet Andersen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janet Andersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janet Andersen. The network helps show where Janet Andersen may publish in the future.

Co-authorship network of co-authors of Janet Andersen

This figure shows the co-authorship network connecting the top 25 collaborators of Janet Andersen. A scholar is included among the top collaborators of Janet Andersen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janet Andersen. Janet Andersen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Godfrey, Catherine, Janet Andersen, Rosie Mngqibisa, Lesley Scott, & Francesca Conradie. (2016). inform investments for health R & D. The Lancet. 1 indexed citations

Nahid, Payam, Jussi Saukkonen, William R. Mac Kenzie, et al.. (2011). Tuberculosis Biomarker and Surrogate Endpoint Research Roadmap. American Journal of Respiratory and Critical Care Medicine. 184(8). 972–979. 41 indexed citations

Grant, Philip, Lauren Komarow, Janet Andersen, et al.. (2010). Risk Factor Analyses for Immune Reconstitution Inflammatory Syndrome in a Randomized Study of Early vs. Deferred ART during an Opportunistic Infection. PLoS ONE. 5(7). e11416–e11416. 119 indexed citations

Wohl, David A., Michelle A. Kendall, Janet Andersen, et al.. (2009). Low Rate of CMV End-Organ Disease in HIV-Infected Patients Despite Low CD4+ Cell Counts and CMV Viremia: Results of ACTG Protocol A5030. HIV Clinical Trials. 10(3). 143–152. 32 indexed citations

King, William D., Kimberly Y. Smith, Janet Andersen, et al.. (2007). Attitudes and Perceptions of AIDS Clinical Trials Group Site Coordinators on HIV Clinical Trial Recruitment and Retention: A Descriptive Study. AIDS Patient Care and STDs. 21(8). 551–563. 24 indexed citations

Blackard, Jason T., Minhee Kang, J. Benjamin St. Clair, et al.. (2007). Viral Factors Associated with Cytokine Expression During HCV/HIV Co-Infection. Journal of Interferon & Cytokine Research. 27(4). 263–270. 8 indexed citations

Steen, Lynn Arthur, Steven R. Dunbar, Sheldon P. Gordon, et al.. (2006). A Fresh Start for Collegiate Mathematics. 18 indexed citations

Marra, Christina M., Natasa Rajicic, David E. Barker, et al.. (2002). A pilot study of cidofovir for progressive multifocal leukoencephalopathy in AIDS. AIDS. 16(13). 1791–1797. 143 indexed citations

Chirgwin, Keith, Richard Hafner, Catherine Leport, et al.. (2002). Randomized Phase II Trial of Atovaquone with Pyrimethamine or Sulfadiazine for Treatment of Toxoplasmic Encephalitis in Patients with Acquired Immunodeficiency Syndrome: ACTG 237/ANRS 039 Study. Clinical Infectious Diseases. 34(9). 1243–1250. 68 indexed citations

10.

Koya, Richard C., Janet Andersen, Hugo F. Fernández, et al.. (1998). Analysis of the value of empiric vancomycin administration in febrile neutropenia occurring after autologous peripheral blood stem cell transplants. Bone Marrow Transplantation. 21(9). 923–926. 13 indexed citations

11.

Meenan, Brian J., et al.. (1996). Terminal Transferase Expression in the Differential Diagnosis of Acute Leukemias. Leukemia & lymphoma. 22(3-4). 265–269. 5 indexed citations

12.

Andersen, Janet. (1995). FEMALE STUDENTS REACT TO COLLABORATIVE LEARNING. PRIMUS. 5(1). 55–60. 3 indexed citations

13.

Wright, Joel E., Anthony Elias, Sylvia A. Holden, et al.. (1995). High-dose ifosfamide, carboplatin, and etoposide pharmacokinetics: correlation of plasma drug levels with renal toxicity. Cancer Chemotherapy and Pharmacology. 36(4). 345–351. 24 indexed citations

14.

Stone, Richard M., Steven H. Bernstein, George D. Demetri, et al.. (1994). Therapy with recombinant human erythropoietin in patients with myelodysplastic syndromes. Leukemia Research. 18(10). 769–776. 13 indexed citations

15.

Colgan, Joseph P., et al.. (1994). Long-Term Foliow-Up of a CHOP-Based Regimen with Maintenance Therapy and Central Nervous System Prophylaxis in Lymphoblastic Non-Hodgkin's Lymphoma. Leukemia & lymphoma. 15(3-4). 291–296. 24 indexed citations

16.

Gordon, Leo I., Janet Andersen, Stephanie Gregory, et al.. (1993). A VM 26-based regimen for patients with previously untreated non-Hodgkin lymphoma. Prolonged disease-free survival in patients younger than 60 years of age: A phase II trial of the eastern cooperative oncology group. Cancer. 71(2). 464–470. 3 indexed citations

17.

Cassileth, Peter A., Janet Andersen, Hillard M. Lazarus, et al.. (1993). Autologous bone marrow transplant in acute myeloid leukemia in first remission.. Journal of Clinical Oncology. 11(2). 314–319. 79 indexed citations

18.

Gordon, Leo I., David Harrington, Janet Andersen, et al.. (1992). Comparison of a Second-Generation Combination Chemotherapeutic Regimen (m-BACOD) with a Standard Regimen (CHOP) for Advanced Diffuse Non-Hodgkin's Lymphoma. New England Journal of Medicine. 327(19). 1342–1349. 260 indexed citations

19.

Nichols, C R, Janet Andersen, Hillard M. Lazarus, et al.. (1992). High-dose carboplatin and etoposide with autologous bone marrow transplantation in refractory germ cell cancer: an Eastern Cooperative Oncology Group protocol.. Journal of Clinical Oncology. 10(4). 558–563. 118 indexed citations

20.

Kramer, Zachary, László G. Boros, Peter H. Wiernik, et al.. (1991). 13-cis-retinoic acid in the treatment of elderly patients with acute myeloid leukemia. A phase II pilot study of the eastern cooperative oncology group. Cancer. 67(6). 1484–1486. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact